Clinical trial
A Phase 2 Study of HKI-272 In Subjects With Advanced Non-Small Cell Lung Cancer
NCT00266877 is registered in ClinicalTrials.gov with Puma Biotechnology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of HKI-272 In Subjects With Advanced Non-Small Cell Lung Cancer
- Lead sponsor
- Puma Biotechnology, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- January 31, 2009
- Enrollment
- 172 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.